- Ayurcann (AYUR) has launched its online cannabis marketplace for medical cannabis consumers
- Canadian medical cannabis consumers will find a competitively priced selection of products including vapes, tinctures and topicals
- Ayurcann has introduced six new products from Fuego, and Ayurcann’s wholly-owned Xplor brand
- Licensed producers can apply to have their qualified products listed on the website
- Ayurcann focuses on the post-harvest solutions for licensed cannabis producers, including extraction, refinement, formulation, packaging, fulfillment and distribution
- Ayurcann Holdings Corp. (AYUR) opened trading at C$0.25 per share
Ayurcann (AYUR) has launched its online cannabis marketplace for medical cannabis consumers in Canada.
The goal of the Ayurcann Marketplace is to provide Canadian medical cannabis consumers with a competitively priced selection of products including vapes, tinctures and topicals.
In conjunction with the launch of the Ayurcann Marketplace, the company has also introduced six new products from Fuego, and Ayurcann’s wholly-owned Xplor brand.
Canadian medical patients may now register with Ayurcann Marketplace and gain access to a growing catalogue of products.
The company is continuously working on building its catalogue of products offered to patients and is expecting to launch three new brands in the coming weeks.
Igal Sudman, CEO of Ayurcann commented on the launch.
“We saw a gap in the current system and thought there had to be a better option for these patients. We know patients and we know that they prefer to transact digitally, while also being offered a wide range of choice at an exceptional price. With the launch of our Marketplace, we feel that we can fulfill that consumer need and showcase to everyone what differentiates us from our competitors.”
The Ayurcann Marketplace will allow licensed producers to apply to have their qualified products listed for sale. Ayurcann will handle customer service, online payments, and fulfillment.
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma-grade products for the adult-use and the medical cannabis industries in Canada.
Ayurcann Holdings Corp. (AYUR) opened trading at C$0.25 per share.